growth-hormoneapproved

Tesamorelin

Tesamorelin (Egrifta)

Overview

An FDA-approved GHRH analog originally for HIV-associated lipodystrophy. Increasingly used off-label for abdominal fat reduction and muscle growth. One of the few FDA-approved GH-related peptides.

Mechanism of Action

Stimulates the pituitary gland to produce and release growth hormone naturally. Unlike synthetic HGH, it works through the body's own regulatory mechanisms.

Popular Research Uses

  • Abdominal fat reduction
  • HIV lipodystrophy (approved use)
  • Muscle growth (off-label)
  • Anti-aging (off-label)
  • Cognitive function

Potential Side Effects

  • Injection site reactions
  • Joint pain
  • Swelling
  • Muscle pain
  • Paresthesia

Warnings

  • Requires prescription
  • Expensive
  • May cause fluid retention
  • Contraindicated with active malignancy
  • Monitor IGF-1 levels

Dosage Information

FDA-approved dosing. Requires prescription and medical supervision.

Research Sources

Disclaimer: This content is for research and educational purposes only. Tesamorelin is not approved for human consumption. Always consult with qualified healthcare professionals before making any decisions related to peptide research.

Follow the research

Explore dated papers and trial records alongside this guide. Each record links to its original source.